Singapore Patent for FGF2 Granted

A Singapore patent Nr. 11201804402W has been granted in respect of an invention of thermostable Fibroblast Growth Factor 2 (FGF2) polypeptide. The engineered FGF2 has improved thermal stability compared to the wild-type and is of use in the cell biology research, regenerative medicine and related medical applications or cosmetics.

Sincere congratulations to all inventors from both Masaryk University and Enantis.

David to Participate in NGSchool2022
Stas to Present at AI for Enzyme Instructed Synthetic Catalysis
David to Present at XXV Biological Days
1st Droplet Sorting in LL
Jiri to Present at Business2Science
Prof. Bornscheuer to Give Lecture at MU
Dean’s Award for Pavel